JaypeeDigital

Speciality

TESTIMONIALS

NEWSLETTERS

Subscribe to be the first to know about Best Deals and Exclusive Offers!

EXPORT CITATION

Chapter-10 Role of MRgFUS in the Management of Fibroids and Adenomyosis

BOOK TITLE: Practical Guide in Reproductive Surgery

Author
1. Govindarajan Mirudhubashini
2. Jayaram Ramya
ISBN
9789352704842
DOI
10.5005/jp/books/18067_11
Edition
1/e
Publishing Year
2018
Pages
12
Author Affiliations
1. Institute of Medical Sciences and Research, Coimbatore, TN, India, Women’s Center, Assisted Reproductive Technology Center, Sri Ramakrishna Hospital Campus, Coimbatore, India, Assisted Reproductive Technology Center, Coimbatore, India, Sri Ramakrishna Hospital, Coimbatore, India, Assisted Reproductive Technology Center, Women’s Center, Coimbatore, Tamil Nadu, India, Womens Center and Hospitals, Mettupalayam Road, Coimbatore, Tamil Nadu, India, Women’s Center, Coimbatore, Tamil Nadu, India, Womens Center and Hospitals, Coimbatore, Tamil Nadu, India, Womens Center, Coimbatore, Tamil Nadu, India, Women’s Center and Hospitals, Coimbatore, Tamil Nadu, India
2. Womens Center, Coimbatore, Tamil Nadu, India, Women’s Center and Hospitals, Coimbatore, Tamil Nadu, India, Motherhood Women and Children’s Hospital, Coimbatore, Tamil Nadu, India
Chapter keywords
Magnetic resonance imaging, MRI, magnetic resonance-guided focused ultrasound, MRgFUS, benign prostatic hyperplasia, BPH, thermal effect, fibroid, adenomyosis, assisted reproduction technique, ART

Abstract

Magnetic resonance imaging (MRI) as a technology has gained importance as a diagnostic and therapeutic modality in current medical practice. The magnetic resonance-guided focused ultrasound (MRgFUS) as a therapeutic modality was first cited and patented in 1992. The use of MRgFUS was subsequently launched in Europe in 1994 after receiving European expanded (CE) approval for benign prostatic hyperplasia (BPH). Magnetic resonance-guided focused ultrasound (MRgFUS) is a thermoablative procedure. It utilizes an external ultrasound energy source to induce thermal ablation is at 65–85°C. This thermal effect is only at the focal point of 2–3 mm and at a given depth through the intact skin. This chapter covers the MRgFUS for fibroids, indications for MRgFUS treatment, MRgFUS treatment in patients with a desire to have children, objectives of treatment and success criteria for MRgFUS treatment, MRgFUS for adenomyosis, and MRgFUS management for adenomyosis.

Related Books

3989 eBooks
11968 Videos
80651 MCQs
91 eJournals

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved